Home › Endometrial Cancer
Endometrial Cancer clinical trials recruiting in the U.S.
167 studies for Endometrial Cancer are recruiting participants at sites across the United States.
Cities with the most studies
- Houston, TX68 studies
- New York City, NY53 studies
- Boston, MA50 studies
- Arlington, VA38 studies
- Nashville, TN37 studies
- Los Angeles, CA35 studies
- St. Louis, MO29 studies
- Philadelphia, PA29 studies
- San Antonio, TX27 studies
- Columbus, OH26 studies
- Oklahoma City, OK26 studies
- Queens, NY26 studies
- Chicago, IL26 studies
- Dallas, TX25 studies
- Pittsburgh, PA24 studies
- Portland, OR24 studies
- Detroit, MI21 studies
- Cleveland, OH21 studies
- Edison, NJ20 studies
- Grand Rapids, MI19 studies
- Rochester, MN19 studies
- Minneapolis, MN19 studies
- Washington, DC19 studies
- Seattle, WA18 studies
- Orlando, FL18 studies
- Atlanta, GA18 studies
- Durham, NC17 studies
- Baldwin Park, CA17 studies
- Austin, TX16 studies
- San Diego, CA16 studies
- Sarasota, FL16 studies
- Denver, CO16 studies
- Miami, FL16 studies
- Birmingham, AL16 studies
- Providence, RI15 studies
- Tampa, FL15 studies
- Salt Lake City, UT15 studies
- New Haven, CT15 studies
- Indianapolis, IN15 studies
- Aurora, CO15 studies
By state
- Alabama19 studies
- Alaska5 studies
- Arizona22 studies
- Arkansas13 studies
- California74 studies
- Colorado31 studies
- Connecticut21 studies
- Delaware5 studies
- District of Columbia11 studies
- Florida65 studies
- Georgia25 studies
- Hawaii3 studies
- Idaho5 studies
- Illinois39 studies
- Indiana20 studies
- Iowa11 studies
- Kansas6 studies
- Kentucky11 studies
- Louisiana16 studies
- Maine8 studies
- Maryland23 studies
- Massachusetts54 studies
- Michigan45 studies
- Minnesota39 studies
- Mississippi5 studies
- Missouri31 studies
- Montana6 studies
- Nebraska11 studies
- Nevada9 studies
- New Jersey33 studies
- New Mexico14 studies
- New York70 studies
- North Carolina32 studies
- North Dakota7 studies
- Ohio50 studies
- Oklahoma29 studies
- Oregon27 studies
- Pennsylvania43 studies
- Rhode Island15 studies
- South Carolina10 studies
- South Dakota11 studies
- Tennessee40 studies
- Texas91 studies
- Utah26 studies
- Virginia51 studies
- Washington21 studies
- West Virginia5 studies
- Wisconsin25 studies
Recently updated studies
Study of AVZO-021 in Patients With Advanced Solid Tumors
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT05867251A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
RecruitingPhase 1
Ages 19 and older · All sexes · Updated Sep 28, 2026 · NCT06586957Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
RecruitingPhase 3
Ages 18 and older · Women · Updated Sep 28, 2026 · NCT05256225Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
RecruitingPhase 2
Ages 18 and older · Women · Updated Sep 28, 2026 · NCT05112601Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RecruitingPhase 2
All ages · All sexes · Updated Sep 28, 2026 · NCT05564377Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers
RecruitingPhase 1/2
Ages 18 and older · Women · Updated Sep 25, 2026 · NCT03564340ctDNA Testing to Inform Standard-of-Care Treatment Decisions in People With Endometrial Cancer
Recruiting
Ages 18 and older · Women · Updated Sep 25, 2026 · NCT07270666DESTINY-PANTUMOUR04
RecruitingObservational study
Ages 18 to 130 · All sexes · Updated Sep 25, 2026 · NCT07124000A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06172478Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
RecruitingPhase 3
Ages 18 and older · Women · Updated Sep 25, 2026 · NCT07198074Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06218914A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT07229313A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab
RecruitingPhase 1/2
Ages 18 and older · Women · Updated Sep 24, 2026 · NCT04590326Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
RecruitingPhase 2
Ages 18 and older · Women · Updated Sep 24, 2026 · NCT05640999Pembrolizumab and Lenvatinib in Mismatch Repair Proficient Recurrent Endometrial Cancer After Progression on or Following First-Line Immunotherapy Maintenance
RecruitingPhase 2
Ages 18 and older · Women · Updated Sep 24, 2026 · NCT07594015Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
RecruitingPhase 2
Ages 18 to 130 · All sexes · Updated Sep 23, 2026 · NCT05489211A Study of LY4257496 in Participants With Cancer (OMNIRAY)
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07114601Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
RecruitingPhase 2
Ages 18 to 72 · All sexes · Updated Sep 22, 2026 · NCT01174121EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07262619Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06128551A Study of Ivonescimab in People With Endometrial and Cervical Cancers
RecruitingPhase 2
Ages 18 and older · Women · Updated Sep 21, 2026 · NCT06925724Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT05983432PROton Therapy for Post Surgical Treatment of GYNecologic Cancer
RecruitingPhase 2
Ages 18 and older · Women · Updated Sep 17, 2026 · NCT05758688A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer
RecruitingPhase 3
Ages 18 and older · Women · Updated Sep 17, 2026 · NCT06340568A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT07109726From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.